TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis
TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis
复制标题
TP 53/p53-FBXO 22-TFEB控制基础自噬以控制兴奋效应
DOI:
10.1080/15548627.2021.1897961
复制
发表时间:
2021-03-13
期刊:
影响因子:
13.3
通讯作者:
Nakanishi, Makoto
中科院分区:
文献类型:
--
作者:
Suzuki, Narumi;Johmura, Yoshikazu;Nakanishi, Makoto
Preconditioning with a mild stressor such as fasting is a promising way to reduce severe side effects from subsequent chemo- or radiotherapy. However, the underlying mechanisms have been largely unexplored. Here, we demonstrate that the TP53/p53-FBXO22-TFEB (transcription factor EB) axis plays an essential role in this process through upregulating basal macroautophagy/autophagy. Mild stress-activated TP53 transcriptionally induced FBXO22, which in turn ubiquitinated KDM4B (lysine-specific demethylase 4B) complexed with MYC-NCOR1 suppressors for degradation, leading to transcriptional induction of TFEB. Upregulation of autophagy-related genes by increased TFEB dramatically enhanced autophagic activity and cell survival upon following a severe stressor. Mitogen-induced AKT1 activation counteracted this process through the phosphorylation of KDM4B, which inhibited FBXO22-mediated ubiquitination. Additionally, fbxo22(-/-) mice died within 10 h of birth, and their mouse embryonic fibroblasts (MEFs) showed a lowered basal autophagy, whereas FBXO22-overexpressing mice were resistant to chemotherapy. Taken together, these results suggest that TP53 upregulates basal autophagy through the FBXO22-TFEB axis, which governs the hormetic effect in chemotherapy.